• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Document › Details

Adaptimmune Therapeutics plc. (5/10/17). "Press Release: Adaptimmune Reports First Quarter 2017 Financial Results". Philadeliphia, PA & Oxford.

	Organisation	Adaptimmune Therapeutics plc (Nasdaq: ADAP)
	Group	Adaptimmune (Group)
	Organisation 2	Matrix Capital Management Company LP
	Product	AFP SPEAR™ T-cell therapy
	Product 2	NY-ESO SPEAR® T-cell therapy
	Index term	Adaptimmune–Matrix Capital Management: investment, 201704 direct offering $42m of 7m ADSs at $6/ADS
	Person	Noble, James (Adaptimmune CEO before MediGene 200609–200809 before Avidex)
	Person 2	Tayton-Martin, Helen (Adaptimmune 201703– CBO before COO + Co-Founder before Avidex/Medigene)

Record changed: 2017-05-28

Advertisement

More documents for Adaptimmune (Group)

• [1] Adaptimmune Therapeutics plc. (5/25/17). "Press Release: Adaptimmune Announces Initiation of Study to Evaluate SPEAR T-Cell Therapy Targeting NY-ESO in Combination with Keytruda (pembrolizumab) in Multiple Myeloma". Philadeliphia, PA & Oxford....
• [2] Adaptimmune Therapeutics plc. (5/16/17). "Press Release: Adaptimmune Announces Initiation of Study to Evaluate SPEAR T-Cell Therapy Targeting MAGE-A4 in Multiple Solid Tumors". Philadeliphia, PA & Oxford....
• [3] Adaptimmune Therapeutics plc. (5/10/17). "Press Release: Adaptimmune Announces Initiation of Study to Evaluate SPEAR T-Cell Therapy Targeting AFP in Liver Cancer". Philadeliphia, PA & Oxford....
• [4] Adaptimmune Therapeutics plc. (5/2/17). "Press Release: Adaptimmune to Present at Upcoming Deutsche Bank 42nd Annual Health Care Conference". Philadeliphia, PA & Oxford....
• [5] Adaptimmune Therapeutics plc. (4/10/17). "Press Release: Adaptimmune Therapeutics plc Announces Closing of $42 Million Registered Direct Offering". Philadeliphia, PA & Oxford....
• [6] Adaptimmune Therapeutics plc. (4/5/17). "Press Release: Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares". Philadeliphia, PA & Oxford....
• [7] Adaptimmune Therapeutics plc. (3/27/17). "Press Release: Adaptimmune Therapeutics plc Announces Closing of Public Offering and Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares". Philadeliphia, PA & Oxford....
• [8] Adaptimmune Therapeutics plc. (3/27/17). "Press Release: Adaptimmune to Participate in Upcoming Jefferies Immuno-Oncology Summit". Philadeliphia, PA & Oxford....
• [9] Adaptimmune Therapeutics plc. (3/22/17). "Press Release: Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares". Philadeliphia, PA & Oxford....
• [10] Adaptimmune Therapeutics plc. (3/21/17). "Press Release: Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares". Philadeliphia, PA & Oxford....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2017. Made in Germany.